The cannabinoid CB, receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake Article

Thornton-Jones, Zoe D, Kennett, Guy A, Benwell, Karen R et al. (2006). The cannabinoid CB, receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake . PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 84(2), 353-359. 10.1016/j.pbb.2006.06.001

Industry Collaboration

cited authors

  • Thornton-Jones, Zoe D; Kennett, Guy A; Benwell, Karen R; Revell, Dean F; Misra, Anil; Sellwood, Daniel M; Vickers, Steven P; Clifton, Peter G

sustainable development goals

authors

publication date

  • June 1, 2006

published in

keywords

  • ACID
  • ADIPOSE-SPECIFIC PROTEIN
  • ANANDAMIDE
  • ANTAGONIST
  • Behavioral Sciences
  • DIO rat
  • ENDOCANNABINOIDS
  • EXPRESSION
  • FAT
  • HYPOTHALAMUS
  • Life Sciences & Biomedicine
  • Neurosciences
  • Neurosciences & Neurology
  • Pharmacology & Pharmacy
  • SR-141716
  • SR141716
  • SR141716A
  • Science & Technology
  • adiponectin
  • body weight
  • food intake
  • paired-feeding
  • rimonabant

Digital Object Identifier (DOI)

publisher

  • PERGAMON-ELSEVIER SCIENCE LTD

start page

  • 353

end page

  • 359

volume

  • 84

issue

  • 2